HEALTH● LOW1h ago · Oct 20, 2026, 12:50 PM
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
CNBC · global
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH15m agoUS records first human case of H5N1 this yearThe TelegraphHEALTH17m agoChristina Applegate says she was misdiagnosed with MSABC NewsHEALTH28m agoTeen girls vape more than boys, study showsCBS NewsHEALTH45m agoWoman's 3-year wait for donor organ exposes complexity of US transplant systemThe Independent World